Drug Overdose Clinical Trials
2 recruiting trials for Drug Overdose. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Drug Overdose clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by CytoSorbents, Inc (1), Johns Hopkins Bloomberg School of Public Health (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is CytoSorb (device, 1 trial), followed by Network overdose prevention, Standard of care health education.
Track Drug Overdose trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
CytOSorb TreatMent Of Critically Ill PatientS Registry
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an...
Social Network Overdose Prevention and Education Intervention
The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Drug Overdose, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Drug Overdose, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Drug Overdose, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.